Chemotherapy in locally advanced head and neck squamous cell carcinoma.

@article{Gyawali2016ChemotherapyIL,
  title={Chemotherapy in locally advanced head and neck squamous cell carcinoma.},
  author={Bishal Gyawali and Tomoya Shimokata and Kazunori Honda and Yuichi Ando},
  journal={Cancer treatment reviews},
  year={2016},
  volume={44},
  pages={
          10-6
        }
}
Chemotherapy, in combination with a local treatment, has a role in nearly all the settings of locally advanced head and neck squamous cell carcinoma (LAHNSCC) treatment: as definitive, adjuvant or induction therapy. However, despite many years of trials, controversies still exist regarding the best approach to using chemotherapy in the multi-modal treatment of LAHNSCC. Opinions are divided on sequential versus concurrent use of chemotherapy and radiotherapy for unresectable LAHNSCC. More debate… CONTINUE READING
BETA
22
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

Low-value practices in oncology contributing to financial toxicity

  • Ecancermedicalscience
  • 2017
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

JP Pignon, A le Maitre, E Maillard, J Bourhis, M-NC. Group
  • Radiother Oncol 2009;92:4–14
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Long-term results of GORTEC 2000–01: A multicentric randomized phase III trial of induction chemotherapy

GPY Janoray, P Garaud
  • Cancer Treatment Reviews
  • 2016
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…